Literature DB >> 3484536

The relationship of anti-DNA antibody idiotypes and anti-cardiolipin antibodies to disease activity in systemic lupus erythematosus.

D A Isenberg, C B Colaco, C Dudeney, A Todd-Pokropek, M L Snaith.   

Abstract

The detection of anti-cardiolipin antibodies and anti-DNA antibody idiotypes has shown utility in a prospective assessment of 42 lupus patients over a 1-year study period. However, so broad is the range of clinical and serological features included in the diagnostic category of SLE that even a combination of tests will often inadequately reflect disease activity at a given time. For the foreseeable future the value of laboratory investigations will probably lie in supporting clinical judgment of the nature of a patient's illness and the severity of the target organ's dysfunction.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3484536     DOI: 10.1097/00005792-198601000-00003

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  15 in total

1.  Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients.

Authors:  R Cervera; J Font; A López-Soto; F Casals; L Pallarés; A Bové; M Ingelmo; A Urbano-Márquez
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

Review 2.  Anti-DNA antibodies as early predictor for disease exacerbations in SLE. Guideline for treatment?

Authors:  P E Spronk; H Bootsma; C G Kallenberg
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

3.  Fluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective study.

Authors:  H J Out; P G de Groot; P Hasselaar; M dan Vliet; R H Derksen
Journal:  Ann Rheum Dis       Date:  1989-12       Impact factor: 19.103

4.  A cross-reactive idiotype on anti-DNA and lymphocytotoxic antibodies.

Authors:  P M Lydyard; D Isenberg; B de Sousa; L Mackenzie; A Cooke
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

5.  Changes in GAD65Ab-specific antiidiotypic antibody levels correlate with changes in C-peptide levels and progression to islet cell autoimmunity.

Authors:  E Ortqvist; B Brooks-Worrell; K Lynch; J Radtke; L M Bekris; I Kockum; C-D Agardh; C M Cilio; A L Lethagen; B Persson; A Lernmark; J Reichow; S Oak; J P Palmer; C S Hampe
Journal:  J Clin Endocrinol Metab       Date:  2010-08-04       Impact factor: 5.958

6.  Evaluation of in vivo immune complex formation and complement activation in patients receiving intravenous streptokinase.

Authors:  J Freysdottir; S Ormarsdottir; A Sigfusson
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

7.  Anticardiolipin antibodies in patients with autoimmune diseases: isotype distribution and clinical associations.

Authors:  J Font; R Cervera; A Lopez-Soto; L Pallares; X Bosch; S Ampurdanes; F J Casals; M Ingelmo
Journal:  Clin Rheumatol       Date:  1989-12       Impact factor: 2.980

8.  B lymphocyte activation in systemic lupus erythematosus: spontaneous production of IgG antibodies to DNA and environmental antigens in cultures of blood mononuclear cells.

Authors:  O Dar; M R Salaman; M H Seifert; D A Isenberg
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

9.  Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus.

Authors:  G Senaldi; V A Makinde; D Vergani; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1988-11       Impact factor: 19.103

10.  Complement split product C3d as an indicator of disease activity in systemic lupus erythematosus.

Authors:  E Röther; B Lang; R Coldewey; K Hartung; H H Peter
Journal:  Clin Rheumatol       Date:  1993-03       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.